Radiopharm Theranostics Ltd
- Ticker
- RADX, RDPTF
- CIK
- 1949257
- Industry
- Pharmaceutical Preparations
Ownership 9
- 4 Statement of changes in beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
- 3 Initial statement of beneficial ownership of securities
Prospectus 7
- 424B3 Prospectus filed pursuant to Rule 424(b)(3)
- 424B5 Prospectus filed pursuant to Rule 424(b)(5)
- 424B5 Prospectus filed pursuant to Rule 424(b)(5)
- 424B3 Prospectus filed pursuant to Rule 424(b)(3)
- 424B5 Prospectus filed pursuant to Rule 424(b)(5)
- 424B3 Prospectus filed pursuant to Rule 424(b)(3)
- DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Other 150
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- SCHEDULE 13G
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
- SCHEDULE 13G
- 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments